PRLD · Prelude Therapeutics Inc

$4.06 -0.14 (-3.33%) At close · Jul 20

Market Cap

$323.36M

79.65M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Krishna Vaddi	CEO	$615,441	—	—	$412,744	$309,465	$10,350	$1,348,000
Bryant D. Lim	CFO	$477,500	—	—	$166,347	$193,200	$10,350	$847,397
Peggy Scherle	Chief Scientific Officer	$473,416	—	—	$145,523	$190,440	$10,350	$819,729

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Krishna Vaddi	CEO	$594,167	—	—	$1,446,379	$276,575	$10,350	$2,327,471
Jane Huang	Director	$568,333	—	—	$595,671	$264,550	$10,350	$1,438,904
Bryant D. Lim	CFO	$444,167	—	—	$581,895	$166,500	$10,350	$1,202,912

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Krishna Vaddi	CEO	$572,667	—	—	$1,735,873	$330,625	$2,624	$2,641,789
Jane Huang	Director	$545,833	—	—	$789,033	$316,250	$3,546	$1,654,662
Bryant D. Lim	CFO	$359,282	—	—	$1,086,904	$159,083	$9,497	$1,614,766

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Krishna Vaddi	CEO	$558,333	—	—	$2,498,244	$238,425	$9,150	$3,304,152
Jane Huang	Director	$391,761	$4,450	$729,000	$1,627,660	$167,344	—	$2,920,215
Peggy Scherle	Chief Scientific Officer	$416,667	$300,000	—	$761,865	$142,800	$9,150	$1,630,482

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Krishna Vaddi	CEO	$544,192	—	—	$6,224,234	$265,688	$8,700	$7,042,814
Brian Piper	CFO	$389,458	—	—	$2,518,565	—	—	$2,908,023
Peggy Scherle	Chief Scientific Officer	$408,271	—	—	$2,068,828	$156,000	$8,700	$2,641,799
Andrew P. Combs	Chief Chemistry Officer	$406,461	—	—	$2,068,828	$156,000	—	$2,631,289
Jane Huang	Director	—	—	—	—	—	—	—

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Krishna Vaddi	CEO	$417,058	—	$1,409,998	$9,576,741	$228,667	—	$11,632,464
Christopher Pierce	Analyst, Needham	$204,029	—	—	$3,594,492	$132,344	—	$3,930,865
Deborah Morosini	Executive Vice President and Chief of Clinical Affairs	$194,466	—	—	$3,594,492	$132,344	—	$3,921,302
Peggy Scherle	Chief Scientific Officer	$347,865	—	—	$2,170,824	$171,552	—	$2,690,241
Andrew P. Combs	Chief Chemistry Officer	$321,538	—	—	$1,533,537	$160,988	—	$2,016,063
Brian Piper	CFO	$328,942	—	—	$1,471,410	$160,988	—	$1,961,340

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Krishna Vaddi	CEO	$315,000	—	$815,000	$828,125	$121,275	—	$2,079,400

Key facts CIK 1678660 CUSIP 74065P101 13F (30d) 2 filings 2 filers Visit website Investor relations